ꓗꓳ-ꓪꓰꓼ ꓠꓯ ꓞꓲꓼ ꓬꓲꓸ ꓫꓵꓼ

ꓗꓳ-ꓪꓰꓼ ꓠꓻ ꓡ ꓢꓴ ꓐꓴ 1 ꓠꓬꓲ 2 ꓢꓶꓽ ꓜꓽ ꓓꓴ ꓠꓯ ꓞꓲꓼ ꓕꓲ ꓫꓵꓽ molnupiravir ꓔꓯ ꓴꓗ (ꓐꓲ-ꓔꓲꓠ) ꓗꓴꓷꓼ ꓠꓯ ꓞꓲꓼ ꓢꓲꓽ ꓒꓽ ꓐꓴ ꓡꓰ ꓡꓰ 2021 ꓘꓳꓼ 11 ꓦ 4 ꓠꓬꓲ ꓕꓯꓽ ꓘꓳ ꓣꓴ ꓗꓷꓳ꓿

“molnupiravir ꓠꓯ ꓞꓲꓼ ꓕꓱ ꓟ ꓠꓬ ꓗꓳ-ꓪꓰꓼ ꓠꓻ ꓫꓬꓹ ꓟ ꓗꓪ ꓮ ꓘꓶꓸ ꓙꓲ ꓖꓴ ꓙꓳ ꓟ ꓢꓷꓸ ꓡꓰꓳ꓿ ꓠꓻ ꓢꓴ 89% ꓓ ꓡꓰ ꓢˍ ꓡꓳ꓿ ꓚ ꓟꓲꓽ ꓓꓽ ꓟ ꓕꓲ ꓟ ꓪꓴꓸ ꓔꓴ ꓟ ꓥ ꓡꓳ꓿ ” ꓐꓰ ꓐꓲ-ꓔꓲꓠ ꓠꓯ ꓞꓲꓼ ꓢꓲꓽ ꓒꓽ ꓓ ꓟ Sajid Javid ꓡꓰ ꓐꓯ ꓡꓳ꓿

molnupiravir ꓠꓯ ꓞꓲꓼ ꓔꓯ Merck, Sharp and Dohme (MSD) ꓐꓰ꓾ Ridgeback Biotherapeutics ꓐꓯ ꓞꓲꓼ ꓫꓬꓹ ꓜꓴ ꓐꓴ ꓔꓺ ꓡꓯ ꓘꓳ ꓢꓲꓸ ꓚꓰꓼ ꓓꓲ ꓩꓴ ꓡ ꓟ ꓥ ꓡꓳ꓿

Photo: BBC